Building Toward JPM 2026: How to Maximize Visibility for Investor Engagement and Strategic Partnering

With some of the biggest investor and partnering conferences of the year approaching—including the 2026 JP Morgan Healthcare Conference, taking place January 12–15 in San Francisco—it’s essential to optimize your communications strategy now to ensure your company shows up strong. From fall investor meetings to one of the most high-profile events on the healthcare calendar, the months ahead are your runway to engage investors and strategic partners, elevate visibility, and articulate your company’s story.

Whether you’re preparing for upcoming conferences this fall or already eyeing JPM, planning early gives you the edge. By developing a clear narrative, polishing your investor materials, and strategically engaging media and stakeholders, your company will be better positioned to stand out.

Investor and Partnering Conferences: A Strategic Opportunity

Investor conferences, including JPM and its satellite events, offer a rare chance to meet multiple high-value investors and strategic partners in a short time. Many investors and partners arrive well-versed in your therapeutic area or modality. For public and pre-commercial companies alike, these meetings offer the opportunity to:

• Strengthen relationships with current investors and strategic partners
• Attract new investor interest
• Share inflection points, company milestones, and strategic priorities
• Gather real-time feedback from investors and partners who understand the landscape

Start with Clear Goals—Fall Conferences and JPM Prep

Fall conferences serve as a critical rehearsal space for JPM. Use this time to test key messages, gather investor and partner feedback, and refine your story before January. Here are the Top 3 questions you should ask yourself:

1. Who is in your current shareholder base—and who’s missing?
2. Which new investors and partners (especially those attending JPM) might be a good fit?
3. How can you evolve your presentation and narrative for JPM’s high stakes setting?

Sharpen Your Story for a High-Visibility Audience

Investors and partners want more than data and a vision they can believe in. Ask yourself these 3 questions:

1. What makes your science or platform uniquely investable?
2. How does your pipeline and strategy support unmet need and market growth?
3. What milestones have you hit and what’s coming up in 2026?

Do you need help answering these questions? Our LHS Immersion® process will help you answer these questions and develop a compelling investor- and partner-ready narrative. Contact us at hello@lavoiehealthscience.com to learn more about how we build narratives and communications plans for our clients.

In our next blog, we’ll explore how to extend your reach and amplify ROI as Q4 momentum builds toward JP Morgan week in San Francisco. Success isn’t about simply showing up—it’s about arriving with purpose, preparation, and the confidence to shape the conversation.